Skip to main content

Femasys Inc

FEMY
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001339005

In the last 90 days, Femasys Inc insiders filed 5 open-market purchases and 0 sales; 19 institutions reported holding it in 13F filings for Q2 2026, worth $8.65M in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Femasys Inc changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of FEMY: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders2824−4
Shares1.69M1.48M−211.8K (−12.5%)
Value$4.80M$1.44M−$3.36M (−70.0%)

New holders (6)

Institutions that held Femasys Inc at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to FEMY in Q4 2023
InstitutionSharesValue% of portfolio
Northern Trust Corp78,670$76.7K0.00%
BlackRock Inc.69,232$67.5K0.00%
State Street Corp39,669$38.7K0.00%
Susquehanna International Group, LLP11,893$11.6K0.00%
Harbour Investments, Inc.1,000$9750.00%
Advisory Services Network, LLC1,000$9750.00%

Sold out (10)

Institutions that held Femasys Inc at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of FEMY in Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
Clear Street LLC249,900$744.7K
Barclays PLC99,003$295.0K
Sassicaia Capital Advisers LLC71,931$214.4K
Renaissance Technologies LLC69,126$206.0K
Schonfeld Strategic Advisors LLC66,800$199.1K
Jane Street Group, LLC45,587$135.8K
UBS Group AG76$226
JPMorgan Chase & Co11$33
Sound Income Strategies, LLC38,888–
Coppell Advisory Solutions LLC39,517–